4//SEC Filing
Harler Mary Beth 4
Accession 0001415889-25-021959
CIK 0001496323other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:23 PM ET
Size
5.8 KB
Accession
0001415889-25-021959
Insider Transaction Report
Form 4
Harler Mary Beth
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Common Stock
2025-08-14−323,680→ 0 total
Footnotes (1)
- [F1]Certain of these shares are represented by previously reported restricted stock units ("RSUs"). Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the "Company"), Concentra Biosciences, LLC, a Delaware limited liability company ("Parent"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), on August 14, 2025, Merger Sub merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock, and each outstanding RSU, was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a "CVR") subject to the terms and conditions of a Contingent Value Rights Agreement.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0002018699
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 5:23 PM ET
- Size
- 5.8 KB